Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe E Redon

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphomaJohn E Janik, John C Morris, Deirdre O'Mahony, et al.
The Journal of Clinical Investigation|July 8, 2025
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STINGYoo Sun Kim, Barzin Y Nabet, Briana N Cortez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical TrialMelissa L Abel, Nobuyuki Takahashi, Cody Peer, et al.
Cancer Discovery|January 30, 2023
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse OutcomesLőrinc Sándor Pongor, Christopher W Schultz, Lorenzo Rinaldi, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Cancer Cell|April 13, 2021
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stressAnish Thomas, Nobuyuki Takahashi, Vinodh N Rajapakse, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphomaJohn E Janik, John C Morris, Deirdre O'Mahony, et al.
The Journal of Clinical Investigation|July 8, 2025
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STINGYoo Sun Kim, Barzin Y Nabet, Briana N Cortez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical TrialMelissa L Abel, Nobuyuki Takahashi, Cody Peer, et al.
Cancer Discovery|January 30, 2023
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse OutcomesLőrinc Sándor Pongor, Christopher W Schultz, Lorenzo Rinaldi, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Cancer Cell|April 13, 2021
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stressAnish Thomas, Nobuyuki Takahashi, Vinodh N Rajapakse, et al.
Pageof 9